BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Booth L, Roberts JL, Ecroyd H, Tritsch SR, Bavari S, Reid SP, Proniuk S, Zukiwski A, Jacob A, Sepúlveda CS, Giovannoni F, García CC, Damonte E, González-Gallego J, Tuñón MJ, Dent P. AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication. J Cell Physiol 2016;231:2286-302. [PMID: 27187154 DOI: 10.1002/jcp.25431] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Mucke HA. Patent highlights August-September 2017. Pharm Pat Anal 2018;7:7-14. [PMID: 29219751 DOI: 10.4155/ppa-2017-0037] [Reference Citation Analysis]
2 Roberts JL, Poklepovic A, Booth L, Dent P. The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells. Cell Signal 2020;70:109573. [PMID: 32087304 DOI: 10.1016/j.cellsig.2020.109573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Booth LA, Roberts JL, Dent P. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib. Semin Cancer Biol 2020;66:129-39. [PMID: 31644944 DOI: 10.1016/j.semcancer.2019.10.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
4 Bailly C, Waring MJ. Pharmacological effectors of GRP78 chaperone in cancers. Biochem Pharmacol 2019;163:269-78. [PMID: 30831072 DOI: 10.1016/j.bcp.2019.02.038] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
5 Rasmussen AL. Host Factors Involved in Ebola Virus Replication. In: Tripp RA, Tompkins SM, editors. Roles of Host Gene and Non-coding RNA Expression in Virus Infection. Cham: Springer International Publishing; 2018. pp. 113-50. [DOI: 10.1007/82_2017_27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Booth L, Albers T, Roberts JL, Tavallai M, Poklepovic A, Lebedyeva IO, Dent P. Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo. Oncotarget 2016;7:40398-417. [PMID: 27259258 DOI: 10.18632/oncotarget.9752] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kohli E, Causse S, Baverel V, Dubrez L, Borges-Bonan N, Demidov O, Garrido C. Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives. Microbiol Mol Biol Rev 2021;:e0003521. [PMID: 34643441 DOI: 10.1128/MMBR.00035-21] [Reference Citation Analysis]
8 Ha DP, Van Krieken R, Carlos AJ, Lee AS. The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection. J Infect 2020;81:452-82. [PMID: 32535155 DOI: 10.1016/j.jinf.2020.06.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
9 Yang CF, Gopula B, Liang JJ, Li JK, Chen SY, Lee YL, Chen CS, Lin YL. Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis. Emerg Microbes Infect 2018;7:187. [PMID: 30459406 DOI: 10.1038/s41426-018-0191-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shin J, Toyoda S, Nishitani S, Fukuhara A, Kita S, Otsuki M, Shimomura I. Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19. Diabetes 2021;70:2745-55. [PMID: 34615619 DOI: 10.2337/db20-1094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sannino S, Brodsky JL. Targeting protein quality control pathways in breast cancer. BMC Biol 2017;15:109. [PMID: 29145850 DOI: 10.1186/s12915-017-0449-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
12 Johnson MM, Collier MA, Hoang KV, Pino EN, Graham-Gurysh EG, Gallovic MD, Zahid MSH, Chen N, Schlesinger L, Gunn JS, Bachelder EM, Ainslie KM. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection. Mol Pharm 2018;15:5336-48. [PMID: 30296381 DOI: 10.1021/acs.molpharmaceut.8b00802] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
13 Dent P, Booth L, Roberts JL, Poklepovic A, Cridebring D, Reiman EM. Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43. Aging (Albany NY) 2021;13:17097-117. [PMID: 34252884 DOI: 10.18632/aging.203297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tan Z, Zhang W, Sun J, Fu Z, Ke X, Zheng C, Zhang Y, Li P, Liu Y, Hu Q, Wang H, Zheng Z. ZIKV infection activates the IRE1-XBP1 and ATF6 pathways of unfolded protein response in neural cells. J Neuroinflammation 2018;15:275. [PMID: 30241539 DOI: 10.1186/s12974-018-1311-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
15 McCarthy MW, Walsh TJ. Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert Rev Anti Infect Ther 2017;15:577-84. [PMID: 28480775 DOI: 10.1080/14787210.2017.1328279] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
16 Abdulrahman BA, Abdelaziz D, Thapa S, Lu L, Jain S, Gilch S, Proniuk S, Zukiwski A, Schatzl HM. The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions. Sci Rep 2017;7:17565. [PMID: 29242534 DOI: 10.1038/s41598-017-17770-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
17 McCarthy MW, Walsh TJ. Drugs currently under investigation for the treatment of invasive candidiasis. Expert Opin Investig Drugs 2017;26:825-31. [PMID: 28617137 DOI: 10.1080/13543784.2017.1341488] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol 2021;114:11-24. [PMID: 34054222 DOI: 10.1016/j.tifs.2021.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Latorre V, Mattenberger F, Geller R. Chaperoning the Mononegavirales: Current Knowledge and Future Directions. Viruses 2018;10:E699. [PMID: 30544818 DOI: 10.3390/v10120699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chen HH, Chen CC, Lin YS, Chang PC, Lu ZY, Lin CF, Chen CL, Chang CP. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78. Antiviral Res 2017;142:158-68. [PMID: 28238876 DOI: 10.1016/j.antiviral.2017.02.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
21 Santos-Gandelman J, Rodrigues ML, Machado Silva A. Future perspectives for cryptococcosis treatment. Expert Opin Ther Pat 2018;28:625-34. [PMID: 30084284 DOI: 10.1080/13543776.2018.1503252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
22 Rayner JO, Roberts RA, Kim J, Poklepovic A, Roberts JL, Booth L, Dent P. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication. Biochem Pharmacol 2020;182:114227. [PMID: 32966814 DOI: 10.1016/j.bcp.2020.114227] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
23 Chengcheng Z, Fuxi Z, Mengjiao G, Baoyang R, Xuefeng W, Yantao W, Xiaorong Z. CSFV protein NS5A activates the unfolded protein response to promote viral replication. Virology 2020;541:75-84. [PMID: 32056717 DOI: 10.1016/j.virol.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang S, Zou Y, Guo Q, Chen J, Xu L, Wan X, Zhang Z, Li B, Chu H. AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward Mycobacterium abscessus. Antimicrob Agents Chemother 2020;64:e00236-20. [PMID: 32482678 DOI: 10.1128/AAC.00236-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Morales Vasquez D, Park JG, Ávila-Pérez G, Nogales A, de la Torre JC, Almazan F, Martinez-Sobrido L. Identification of Inhibitors of ZIKV Replication. Viruses 2020;12:E1041. [PMID: 32961956 DOI: 10.3390/v12091041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Welch SR, Spengler JR, Genzer SC, Chatterjee P, Flint M, Bergeron É, Montgomery JM, Nichol ST, Albariño CG, Spiropoulou CF. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform. Viruses 2021;13:1255. [PMID: 34203149 DOI: 10.3390/v13071255] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R. The wide utility of rabbits as models of human diseases. Exp Mol Med 2018;50:1-10. [PMID: 29789565 DOI: 10.1038/s12276-018-0094-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
28 Park JG, Ávila-Pérez G, Nogales A, Blanco-Lobo P, de la Torre JC, Martínez-Sobrido L. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. J Virol 2020;94:e02149-19. [PMID: 31941776 DOI: 10.1128/JVI.02149-19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
29 Booth L, Poklepovic A, Dent P. Not the comfy chair! Cancer drugs that act against multiple active sites. Expert Opin Ther Targets 2019;23:893-901. [PMID: 31709855 DOI: 10.1080/14728222.2019.1691526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]